Exagen inc. reports strong third quarter 2023 results

San diego, california, nov. 13, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended september 30, 2023.

XGN Ratings Summary

XGN Quant Ranking